SEC Form 4 · accession 0001209191-17-029933
FATE THERAPEUTICS INC · FATE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amir Nashat
Director
Period of report
May 2, 2017
Accepted (ET)
May 4, 2017 · 12:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $4.73 | May 2, 2017 | A | 25,000 | A | — | May 1, 2027 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.
- F2Not applicable.